Medistim Delivers Best Quarter Ever

Medistim delivers its best quarter ever and sales ended at MNOK 66.1 (MNOK 52.2), a growth of 26.6 %. Sales for 2014 ended at MNOK 214.8 (MNOK 191.0), a growth of 12.5 %. The atrong…

Read more

Results for the Third Quarter 2014

Sales for the quarter ended at MNOK 52.0 (MNOK 44.3), a growth of 17 %. Sales as of September ended at MNOK 148.7 (MNOK 138.8), a growth of 7.1 %. • Continued strong growth in…

Read more

MiraQ™ Cardiac Launched in the European Market

(Oslo, 13 October 2014) Medistim ASA (OSE: MEDI), a Norwegian company that develops and commercializes medical equipment for use in cardiac, vascular and transplant surgery, announces that they launch its new product MiraQ Cardiac in…

Read more

Record Sales in Fourth Quarter 2013

Medistim delivers record sales for a quarter with MNOK 52.2 (MNOK 49.7). Sales for 2013 ended at MNOK 191 (MNOK 183.8), which is a 3.9 % growth. Operating profit (EBIT) for the quarter ended at…

Read more

Results for the Third Quarter 2013

Sales for the quarter ended at MNOK 44.3 (MNOK 45.0). Sales as of September ended at MNOK 138.8 (MNOK 134.0). It was a strong quarter for procedural sales in the US with the highest number…

Read more

Healthier Veterans Magazine

Published: Winter 2012 (November) Cardiac surgeries performed at Washington DC VA Medical Center (DCVAMC) are now safer and more accurate thanks to the latest intra-operative tool, the Medistim VeriQC.  Winter-2012-Healthier-Veterans-News

Read more